Hey there! Welcome!
Get updated on
ERS 2026_CH web banner-01
ERS 2026_CH web banner-02
ERS 2026_CH web banner-02
Top Picks

calendar
13 Nov, 26
dot
link
AHA 2026
The sessions presented at AHA 2026, underscore the importance of secondary prevention in MI patients and focus on the benefits of beta-blocker treatment and reperfusion treatment in these patients.

calendar
12 Nov, 26
dot
link
AHA 2026
The AHA highlights focus on risk-guided intensive BP control, novel aldosterone synthase inhibitors, GLP-1RA–mediated BP reduction, digital BP management, and real-world combination therapy outcomes.

calendar
17 Nov, 26
dot
link
Eur J Prev Cardiol.
  • Elevated remnant cholesterol [≥1 mmol/L (39 mg/dL)] was more prevalent in familial hypercholesterolemia (FH) population (12%-78%) vs non-FH individuals (11%-12%)
  • Across CGPS & UK Biobank, remnant cholesterol ≥1 mmol/L was associated with higher CAD risk in FH (HRs 1.14-1.60) & non-FH subjects (HR 1.47-1.49), conferring an approximately 50% additional CAD risk beyond lifelong LDL-C elevation in FH individuals.

calendar
17 Nov, 26
A 35-year-old woman with ESRD on maintenance hemodialysis experienced recurrent decompensated HFrEF (LVEF 28%), with severe MR and TR, and pulmonary hypertension despite medical therapy. Click here to read the treatment.

calendar
17 Nov, 26
A 20-month-old girl developed blistering after amoxicillin therapy, with characteristic “string-of-pearls” lesions. Persistent blistering despite initial treatment required escalation for refractory linear IgA bullous dermatosis. Click here to read the treatment.

calendar
16 Nov, 26
dot
link
BMC Pedia
  • Using hemoglobin and serum ferritin , normal iron status was observed in 82-90% of infants during the first year.
  • Iron deficiency prevalence increased from 5.6-11.5% (Hb+SF) to 20.2-27.7% when zinc protoporphyrin (ZnPP) was included.
  • Anemia affected 4.5-7.7% of infants; >50% of cases were non-iron deficiency anemia (non-IDA), and biomarker agreement was low.